ArticlePloS one2025

Analytical validation and sequencing coverage studies suggest that performance of a liquid biopsy assay is tumor agnostic (DNA-is-DNA).

Wei Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.